Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glioblastoma: looking at the currently marketed sigma-1 agonists and antagonists.

Literature DB >> 17786188

Glioblastoma: looking at the currently marketed sigma-1 agonists and antagonists.

Richard E Kast.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2007 PMID： 17786188 PMCID： PMC1950439 DOI： 10.1593/neo.07451

Source DB: PubMed Journal: Neoplasia ISSN： 1476-5586 Impact factor: 5.715

× No keyword cloud information.

10 in total

1. Interaction with sigma(1) protein, but not N-methyl-D-aspartate receptor, is involved in the pharmacological activity of donepezil.

Authors: Tangui Maurice; Johann Meunier; Bihua Feng; John Ieni; Daniel T Monaghan
Journal: J Pharmacol Exp Ther Date: 2006-01-05 Impact factor: 4.030

Review 2. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor.

Authors: Stephen M Stahl
Journal: CNS Spectr Date: 2005-04 Impact factor: 3.790

3. [123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challenge.

Authors: James M Stone; Erik Arstad; Kjell Erlandsson; Rikki N Waterhouse; Peter J Ell; Lyn S Pilowsky
Journal: Synapse Date: 2006-08 Impact factor: 2.562

4. Dextromethorphan psychosis, dependence and physical withdrawal.

Authors: Shannon C Miller
Journal: Addict Biol Date: 2005-12 Impact factor: 4.280

5. Small molecule antagonists of the sigma-1 receptor cause selective release of the death program in tumor and self-reliant cells and inhibit tumor growth in vitro and in vivo.

Authors: Barbara A Spruce; Lorna A Campbell; Niall McTavish; Michelle A Cooper; M Virginia L Appleyard; Mary O'Neill; Jacqueline Howie; Jayne Samson; Stephen Watt; Karen Murray; Doris McLean; Nick R Leslie; Stephen T Safrany; Michelle J Ferguson; John A Peters; Alan R Prescott; Gary Box; Angela Hayes; Bernard Nutley; Florence Raynaud; C Peter Downes; Jeremy J Lambert; Alastair M Thompson; Suzanne Eccles
Journal: Cancer Res Date: 2004-07-15 Impact factor: 12.701

6. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors.

Authors: Kenji Hashimoto; Yuko Fujita; Masaomi Iyo
Journal: Neuropsychopharmacology Date: 2006-02-22 Impact factor: 7.853

7. Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine.

Authors: Magali Peeters; Pascal Romieu; Tangui Maurice; Tsung-Ping Su; Jean-Marie Maloteaux; Emmanuel Hermans
Journal: Eur J Neurosci Date: 2004-04 Impact factor: 3.386

8. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.

Authors: Véronique Mégalizzi; Véronique Mathieu; Tatjana Mijatovic; Philippe Gailly; Olivier Debeir; Nancy De Neve; Marc Van Damme; Gianluca Bontempi; Benjamin Haibe-Kains; Christine Decaestecker; Yasuko Kondo; Robert Kiss; Florence Lefranc
Journal: Neoplasia Date: 2007-05 Impact factor: 5.715

9. Antitussive activity of sigma-1 receptor agonists in the guinea-pig.

Authors: Claire Brown; Malika Fezoui; William M Selig; Carl E Schwartz; James L Ellis
Journal: Br J Pharmacol Date: 2003-12-22 Impact factor: 8.739

10. Irreversible blockade of sigma-1 receptors by haloperidol and its metabolites in guinea pig brain and SH-SY5Y human neuroblastoma cells.

Authors: Enrique J Cobos; Esperanza del Pozo; José M Baeyens
Journal: J Neurochem Date: 2007-04-10 Impact factor: 5.372